OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001538927

Forma Therapeutics Holdings, Inc.

Forma Therapeutics Holdings, Inc. (CIK 0001538927, EIN 37-1657129) reported revenue of $0 for FY2021 (2021-01-01 to 2021-12-31) and net income of -$172.96 million (-$172,964,000) for FY2021 (2021-01-01 to 2021-12-31), as filed in its 10-K filed 2022-03-01 (accession 0000950170-22-002527).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001538927
EIN37-1657129
SIC industry code2836 Biological Products, (No Diagnostic Substances)
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryLarge accelerated filer
Entity typeoperating
Olympus entity IDorg_3dznefmy4sbxfb3zq5va60vs0x
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$0FY20212021-01-01 to 2021-12-3110-K2022-03-010000950170-22-002527Revenues
Net income-$172,964,000FY20212021-01-01 to 2021-12-3110-K2022-03-010000950170-22-002527NetIncomeLoss
Total assets$561,061,000FY2021as of 2021-12-3110-K2022-03-010000950170-22-002527Assets
Total liabilities$62,705,000FY2021as of 2021-12-3110-K2022-03-010000950170-22-002527Liabilities
Stockholders' equity$498,356,000FY2021as of 2021-12-3110-K2022-03-010000950170-22-002527StockholdersEquity
Operating cash flow-$149,787,000FY20212021-01-01 to 2021-12-3110-K2022-03-010000950170-22-002527NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$3.65 per shareFY20212021-01-01 to 2021-12-3110-K2022-03-010000950170-22-002527EarningsPerShareBasicAndDiluted
Shares outstanding47,472,985 sharesFY2021as of 2022-02-2210-K2022-03-010000950170-22-002527EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2012-2021, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20212021-01-01 to 2021-12-31$010-K2022-03-010000950170-22-002527
RevenueFY20202020-01-01 to 2020-12-31$010-K2022-03-010000950170-22-002527
Net incomeFY20212021-01-01 to 2021-12-31-$172,964,00010-K2022-03-010000950170-22-002527
Net incomeFY20202020-01-01 to 2020-12-31-$70,414,00010-K2022-03-010000950170-22-002527

Recent 10-K and 10-Q filings

All 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2022-08-052022-06-300000950170-22-015118fmtx-20220630.htm
10-Q2022-05-062022-03-310000950170-22-008130fmtx-20220331.htm
10-K2022-03-012021-12-310000950170-22-002527fmtx-20211231.htm
10-Q2021-11-122021-09-300000950170-21-004376fmtx-20210930.htm
10-Q2021-08-132021-06-300001564590-21-044302fmtx-10q_20210630.htm
10-Q2021-05-142021-03-310001564590-21-028009fmtx-10q_20210331.htm
10-K2021-03-302020-12-310001564590-21-016642fmtx-10k_20201231.htm
10-Q2020-11-122020-09-300001564590-20-053556fmtx-10q_20200930.htm
10-Q2020-08-132020-06-300001564590-20-040007fmtx-10q_20200630.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001538927published by the sourcedata.sec.gov/submissions/CIK0001538927.json2026-10-21
Employer Identification Number (EIN) · US-EIN37-1657129published by the sourcedata.sec.gov/submissions/CIK0001538927.json2026-10-21

Former names

NameFromTo
Forma Therapeutics Holdings, Inc.,2020-04-082020-07-30
Forma Therapeutics Holdings LLC2012-01-172012-09-06

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001538927.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001538927.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001538927" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001538927/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001538927/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1538927"}

On SEC EDGAR

About this data